Fresenius SE EBIT 2016-2024 | FSNUY

Fresenius SE annual and quarterly EBIT history from 2016 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Fresenius SE EBIT for the quarter ending June 30, 2024 was $0.284B, a 51.98% decline year-over-year.
  • Fresenius SE EBIT for the twelve months ending June 30, 2024 was $0.691B, a 77.14% decline year-over-year.
  • Fresenius SE 2023 annual EBIT was $1.237B, a 64.65% decline from 2022.
  • Fresenius SE 2022 annual EBIT was $3.499B, a 28.87% decline from 2021.
  • Fresenius SE 2021 annual EBIT was $4.919B, a 1.79% decline from 2020.
Fresenius SE Annual EBIT
(Millions of US $)
2023 $1,237
2022 $3,499
2021 $4,919
2020 $5,009
2019 $5,187
2018 $6,201
2017 $5,187
2016 $4,788
2015 $4,303
Fresenius SE Quarterly EBIT
(Millions of US $)
2024-06-30 $284
2024-03-31 $607
2023-12-31 $-576
2023-09-30 $377
2023-06-30 $592
2023-03-31 $845
2022-12-31 $694
2022-09-30 $893
2022-06-30 $899
2022-03-31 $1,012
2021-12-31 $1,288
2021-09-30 $1,189
2021-06-30 $1,230
2021-03-31 $1,213
2020-12-31 $1,230
2020-09-30 $1,301
2020-06-30 $1,237
2020-03-31 $1,241
2019-12-31 $1,408
2019-09-30 $1,255
2019-06-30 $1,257
2019-03-31 $1,266
2018-12-31 $1,400
2018-09-30 $1,210
2018-06-30 $2,317
2018-03-31 $1,273
2017-12-31 $1,298
2017-09-30 $1,309
2017-06-30 $1,284
2017-03-31 $1,296
2016-12-31 $1,346
2016-09-30 $1,197
2016-06-30 $1,187
2016-03-31 $1,058
2015-12-31 $7,951
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.704B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00